Joshua B Cohen
Director, Co-Chief Executive Officer · 6 filings · Latest: Sep 10, 2026
Amylyx Pharmaceuticals, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
AMLX | Joshua B Cohen | Director, Co-Chief Executive Officer | Sep 10, 2026 | Sale | $32.19 | 30,464 | $980.5K | 3,613,123 | |
AMLX | Cohen Joshua B | — | Sep 10, 2026 | Proposed Sale | $32.19 | 30,464 | $980.5K | — | |
AMLX | Joshua B Cohen | Director, Co-Chief Executive Officer | Mar 2, 2026 | Sale | $14.48 | 29,282 | $424.1K | 3,334,683 | |
AMLX | Cohen Joshua B | — | Mar 2, 2026 | Proposed Sale | $14.48 | 29,282 | $424.1K | — | |
AMLX | Joshua B Cohen | Director, Co-Chief Executive Officer | Feb 2, 2026 | Sale | $14.68 | 15,500 | $227.6K | 3,363,965 | |
AMLX | Cohen Joshua B | — | Feb 2, 2026 | Proposed Sale | $14.68 | 15,500 | $227.6K | — | |
AMLX | Joshua B Cohen | Director, Co-Chief Executive Officer | Jan 16, 2026 | Sale | $13.83 | 1,974 | $27.3K | 3,379,465 | |
AMLX | Joshua B Cohen | Director, Co-Chief Executive Officer | Jan 16, 2026 | Option Exercise | $7.57 | 2,818 | $21.3K | 3,381,439 | |
AMLX | Joshua B Cohen | Director, Co-Chief Executive Officer | Jan 15, 2026 | Sale | $13.59 | 136,193 | $1.9M | 3,378,621 | |
AMLX | Joshua B Cohen | Director, Co-Chief Executive Officer | Jan 15, 2026 | Option Exercise | $7.57 | 197,182 | $1.5M | 3,514,814 | |
AMLX | JOSHUA COHEN | — | Jan 16, 2026 | Proposed Sale | $13.52 | 1,974 | $26.7K | — | |
AMLX | JOSHUA COHEN | — | Jan 15, 2026 | Proposed Sale | $14.07 | 136,193 | $1.9M | — | |
AMLX | Cohen Joshua B | — | Jan 6, 2026 | Proposed Sale | $11.09 | 7,715 | $85.6K | — |